Brain Health and Aging, In Collaboration with AARP
Thursday, July 18th 3:30pm-4:30pm via Zoom. Click HERE to Register!
Open Mobile Menu
Brain Health and Aging, In Collaboration with AARP
Thursday, July 18th 3:30pm-4:30pm via Zoom. Click HERE to Register!
Open Mobile Menu

Memory Matters: How Innovative New Alzheimer’s Drug Leqembi Is Making Waves With FDA-Approval

Kensington Park Senior Living is more than just a place to reside, it is a community where everyone is cherished and celebrated as a part of the Kensington Park family. That is why we are optimistic about the recent dementia treatment Leqembi approval and how it can help our residents and loved ones.

Recently, we organized an insightful event, centered around this recent development: “Exploring the New FDA-Approved Treatment for Dementia: How Can Leqembi Help My Loved One?”.

Guided by Neurologist Kenneth Wogensen, MD expertise, we explored the different aspects of the Leqembi medication:

  • Basic Science: How Leqembi fights amyloid plaques in the brain
  • Efficacy: Clinical trials results and FDA approval process
  • Impact: Who is eligible and why, side effects
  • Accessibility: Medicare coverage

Read on to learn more about the event, our speaker, Leqembi’s approval, and how it could be the key to slowing the progress of your loved one’s dementia.

Celebrated neurologist Dr. Kenneth K. Wogensen leads the discussion on dementia care

Kensington Park Senior Living was privileged to have Dr. Kenneth K. Wogensen, a celebrated neurologist with over three decades of experience, lead our event discussion about the new drug, Leqembi.

Having graduated from the University of California, Irvine School of Medicine, Wogensen refined his expertise during his neurology residency at the University of San Diego School of Medicine. That was followed by a fellowship at Stanford Neurology Unit.

In alignment with Kensington Park’s own Promise, Dr. Wogensen emphasizes a family-focused approach, ensuring patients and their families are central to the care process.

His extensive knowledge of various conditions including dementia and Alzheimer’s disease, made him the ideal expert for our event about the recent Leqembi approval and the new optimism surrounding dementia and Alzheimer’s care.

An in-depth look at Leqembi

Leqembi has been found to be most effective for early to middle-stage Alzheimer’s in seniors. Clinical trials have shown that it is possible to slow or completely stop the progression of the disease with this drug.

The FDA fast-tracked its approval in January via its Accelerated Approval route, designed for urgent medical solutions. The drug’s capability to reduce brain amyloid plaques associated with Alzheimer’s played a crucial role in its endorsement.

Such quick approval underscores Leqembi’s promise in sustaining patients’ thinking and daily life abilities.

This approval was anchored in Study 301 (CLARITY AD), a meticulous Phase 3 test of the drug. In this study, 1,795 Alzheimer’s patients with early cognitive challenges and verified brain amyloid presence participated.

Leqembi showed a “statistically significant and clinically meaningful reduction of decline” in its participants over the course of 18 months.

Before this development, Alzheimer’s was previously irreversible. Leqembi is providing hope for families affected by memory disease everywhere.

Criteria for Receiving Leqembi Treatment

Leqembi is given through an IV at medical facilities every two weeks, intended for those at the onset of Alzheimer’s or with mild cognitive symptoms leading to Alzheimer’s. If infusion therapy companies are able to provide this, Kensington Park’s hope is to be able to do this onsite to qualified residents.

In the US, approximately 1.5 million individuals might benefit from Leqembi.

The FDA recommends that before starting Leqembi, patients should be tested for amyloid protein accumulation in the brain. This can be checked using specialized scans, spinal fluid examinations, or recent blood tests.

Seniors must be diagnosed with early-stage Alzheimer’s or mild cognitive impairment due to Alzheimer’s by a doctor and be registered with Medicare Part B to qualify for Leqembi.

Kensington Park’s commitment to excellence and education

In the rapidly evolving world of medicine and healthcare, staying updated with the latest research and breakthroughs is paramount.

At Kensington Park, we take this responsibility seriously, ensuring our community remains at the forefront of medical knowledge. This is rooted in living Our Promise to love and care for your family as we do our own.

Collaboration with medical experts

One of the standout features of our approach is our collaboration with renowned medical professionals.

By partnering with these experts, we ensure that our practices, therapies, and interventions are based on the most recent and proven scientific knowledge. Their insights are invaluable in guiding our care methods and protocols.

Educational events

Knowledge is most effective when shared. Recognizing this, we regularly organize educational events, seminars, and workshops for our residents, their families, and the wider community.

These events, led by medical experts, shed light on various topics, from specific conditions like dementia to broader healthcare trends.

Our recent session on the FDA-approved treatment, Leqembi, for dementia, is a testament to our commitment to keeping our community informed and providing the hope that caregivers and their loved ones need.

Empowering families and caregivers

For many, navigating the maze of medical information can be overwhelming. Our initiatives aim to simplify complex medical topics, making them accessible and understandable.

By doing so, we empower families and caregivers to make informed decisions and foster a sense of confidence and assurance.

Our events play an essential role in our community, bringing us all closer and enriching our collective experiences. Through our events, partnerships, and constant learning, we aim to set a benchmark in senior care and community education. 

Nestled in a serene environment, Kensington Park is dedicated to providing seniors with a harmonious blend of comfort, care, and luxury all while treating them as a part of the Kensington Park family.

Be a part of the Kensington Park family today

At Kensington Park Senior Living, we are not only care providers but partners in your journey toward understanding and navigating the world of dementia and Alzheimer’s.

Our independent living, assisted living, and three levels of memory care communities offer residents various amenities and services, ranging from around-the-clock medical care to life-enrichment activities and exquisite dining.

If you have questions or concerns about your loved one lingering in your mind, or if you simply need a pillar of support—The Kensington Park team is here for you.

Don’t hesitate to reach out to Kensington Park today, and we will embark on this journey together. You will soon come to understand what we mean when we talk about living up to Our Promise to love and care for your family as we do our own.

The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.